MHE August 2021

August 19, 2021

Screening and vaccination against HPV have reduced the incidence of cervical cancer, but researchers say some women are being screened for cervical caner too often — partly because of vaccination.

August 18, 2021

The first half of 2021 saw 372 deals averaging $39.6 million, which is already more than the total value of the deals done in all of 2020.

August 17, 2021

Many people ignored heart disease signs and symptoms during the COVID-19 pandemic — sometimes with grave consequences.

August 16, 2021

FDA approval of Lumakras was contingent on a trial testing lower doses. It could usher in a new era of optimal dosing instead of the maximum tolerated dosing.

August 13, 2021

Accelerated approval and use of surrogate markers are among the friction points. But some see the OK as spawning a new generation of drug development for treating Alzheimer’s disease.

August 11, 2021

Artificial intelligence can help deal with everyday problems such as prior authorization and high utilization. But payers are also eyeing it for loftier purposes.

August 10, 2021

The FDA’s controversial approval of Aduhelm (aducanumab) has put a spotlight on the accelerated approval pathway that the agency used to approve the drug.

August 09, 2021

One-quarter of Medicaid claims result in a denial of payment for at least one service included in the claim compared with just 7.3% of claims submitted to Medicare and 4.8% of claims submitted to commercial insurers

August 09, 2021

It's rate-setting season for insurers, although the full picture for 2022 premiums won’t emerge for some months yet.